Gland Pharma appoints Shyamakant Giri as CEO
Giri is currently the President (India Business & Emerging Markets) of Amneal Pharmaceuticals
Giri is currently the President (India Business & Emerging Markets) of Amneal Pharmaceuticals
MedGenome reaffirms its commitment to broaden access to quality and affordable genetic solutions for all
Buckley served as Chairman and Chief Executive Officer at Vanguard from 2018 until his retirement in 2024
The share subscription agreements are being executed at a pre-money equity value of US$ 1.65 billion
GBM affects nearly 13,000 patients annually in the US and approximately 300,000 globally
He will join in place of Anil Arora, current President- Formulations Operations who will be superannuating in November, 2024
The partnership marks a pivotal step towards developing new therapies for combating Sickle Cell Disease
Paliperidone extended-release tablets will be produced at the Group’s manufacturing site at SEZ, Ahmedabad
We now rank 3rd in pharmaceutical production by volume and 14th by value
WEF recognises company’s Bharuch manufacturing facility as a global manufacturing lighthouse
Subscribe To Our Newsletter & Stay Updated